Recent Funding
Companies
Cardurion Pharmaceuticals

Cardurion Pharmaceuticals

Transforming the treatment of cardiovascular disease and heart failure

Latest funding

$260M Series B+ · July 16, 2024

Led by Ascenta Capital · Source: fundraisingfox.com

Funding history ↓

Website: cardurion.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Health Care, Medical, Pharmaceutical.

Stage: Series B+.

Based in: Burlington, United States.

Founded: 2016.

Last round: Jul 16, 2024 · 849 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredMay 12, 2016 (10 years old)

Funding rounds

July 16, 2024
Series B+ · $260M
AAscenta Capital (lead), BBain Capital Private Equity, BBlue Owl Capital, DDelos Capital, DDigitalis Ventures, FFarallon Capital Management, FFidelity, GGV, IInvus, MMillennium Management, NNEA
Source: fundraisingfox.com
May 12, 2016
Website created

Founders and team

MM
Michael Mendelsohn Founder

LinkedIn
ER
Elizabeth Radcliffe Chief Financial Officer
HS
Howard Surks Chief Medical Officer and Head of Translational Medicine
MM
Marcia Moore Chief Operating Officer

Investors

Companies like Cardurion Pharmaceuticals

UUltromics$55M Series B+ · Aug 2025
CCytoHubPre Seed · Mar 2026
IImpulse DynamicsSeries B+ · Dec 2025
PPuzzle MedicalSeries A · Feb 2023
BBrano Therapeutics$6.8M Seed · May 2026
BBioCardia$4.4M · Jun 2026

Other companies backed by Ascenta Capital

TTriana Bio$120M Series B+ · Dec 2025

Ascenta Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cardurion-pharmaceuticals (get a free API key).